Galcanezumab: a monoclonal antibody for migraine prophylaxis.
- Published in:
- Prescriber, 2020, v. 31, n. 2, p. 33, doi. 10.1002/psb.1826
- By:
- Publication type:
- Article
Works matching IS 09596682 AND DT 2020 AND VI 31 AND IP 2
Results: 6
1
2
Investigation and management of giant cell arteritis.
- Published in:
- Prescriber, 2020, v. 31, n. 2, p. 28, doi. 10.1002/psb.1825
- By:
- Publication type:
- Article
3
Managing the symptoms of Huntington's disease.
- Published in:
- Prescriber, 2020, v. 31, n. 2, p. 23, doi. 10.1002/psb.1824
- By:
- Publication type:
- Article
4
Drug discovery and development: the final frontier.
- Published in:
- Prescriber, 2020, v. 31, n. 2, p. 18, doi. 10.1002/psb.1823
- By:
- Publication type:
- Article
5
Identifying and managing autism in adults.
- Published in:
- Prescriber, 2020, v. 31, n. 2, p. 12, doi. 10.1002/psb.1822
- By:
- Publication type:
- Article
6
'It's a virus, Jim, but not as we know it...'.
- Published in:
- Prescriber, 2020, v. 31, n. 2, p. 4, doi. 10.1002/psb.1821
- By:
- Publication type:
- Article